{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T14:27:15Z","timestamp":1791815235994,"version":"4.3.4"},"reference-count":60,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003947","name":"Universidad Nacional de La Plata","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003947","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Discovery Today"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.drudis.2025.104522","type":"journal-article","created":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T15:52:22Z","timestamp":1762012342000},"page":"104522","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Advances in copper complexes in cancer treatment"],"prefix":"10.1016","volume":"30","author":[{"given":"Luc\u00eda M.","family":"Balsa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luc\u00eda","family":"Santa Maria de la Parra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivia","family":"Espindola-Moreno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1010-3997","authenticated-orcid":false,"given":"Ignacio E.","family":"Le\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.drudis.2025.104522_b0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2022.115323","article-title":"Cisplatin in cancer treatment","volume":"206","author":"Romani","year":"2022","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.drudis.2025.104522_b0010","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1080\/17568919.2024.2383166","article-title":"Transition metal complexes: a new generation of anticancer drugs","volume":"16","author":"Le\u00f3n","year":"2024","journal-title":"Future Med Chem"},{"key":"10.1016\/j.drudis.2025.104522_b0015","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1002\/2211-5463.13381","article-title":"Metallodrugs: an approach against invasion and metastasis in cancer treatment","volume":"12","author":"Gonz\u00e1lez-Ballesteros","year":"2022","journal-title":"FEBS Open Bio"},{"key":"10.1016\/j.drudis.2025.104522_b0020","doi-asserted-by":"crossref","first-page":"13113","DOI":"10.1021\/acs.jmedchem.5c01235","article-title":"Development of a high-efficacy and low-toxicity cobalt(II) agent for targeting inhibition of tumor growth through mitochondrial damage-mediated chemotherapy and immunotherapy","volume":"68","author":"Zhu","year":"2025","journal-title":"J Med Chem"},{"key":"10.1016\/j.drudis.2025.104522_b0025","doi-asserted-by":"crossref","first-page":"19573","DOI":"10.1021\/acs.jmedchem.4c01908","article-title":"Developing an arene binuclear ruthenium(II) complex to induce ferroptosis and activate the cGAS-STING pathway: targeted inhibiting growth and metastasis of triple negative breast cancer","volume":"67","author":"Xu","year":"2024","journal-title":"J Med Chem"},{"key":"10.1016\/j.drudis.2025.104522_b0030","doi-asserted-by":"crossref","first-page":"16296","DOI":"10.1021\/acs.jmedchem.4c01175","article-title":"Developing a palladium(II) agent to overcome multidrug resistance and metastasis of liver tumor by targeted multiacting on tumor cell, inactivating cancer-associated fibroblast and activating immune response","volume":"67","author":"Jiang","year":"2024","journal-title":"J Med Chem"},{"key":"10.1016\/j.drudis.2025.104522_b0035","doi-asserted-by":"crossref","first-page":"510","DOI":"10.2174\/0929867328666211117094550","article-title":"Copper complexes as antitumor agents: in vitro and in vivo evidences","volume":"30","author":"Balsa","year":"2023","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.drudis.2025.104522_b0040","first-page":"15","article-title":"Strategies to combat cancer drug resistance: focus on copper metabolism and cuproptosis","volume":"8","author":"Yao","year":"2025","journal-title":"Cancer Drug Resist (Alhambra, Calif)"},{"key":"10.1016\/j.drudis.2025.104522_b0045","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.3390\/molecules30102104","article-title":"Innovative approaches in the synthesis and optimization of copper complexes for antitumor therapies: a comprehensive review","volume":"30","author":"Silva","year":"2025","journal-title":"Molecules"},{"key":"10.1016\/j.drudis.2025.104522_b0050","doi-asserted-by":"crossref","first-page":"2863","DOI":"10.3390\/cancers12102863","article-title":"Copper complexes as anticancer agents targeting topoisomerases I and II","volume":"12","author":"Molinaro","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.drudis.2025.104522_b0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.jinorgbio.2021.111634","article-title":"Copper in tumors and the use of copper-based compounds in cancer treatment","volume":"226","author":"da Silva","year":"2022","journal-title":"J Inorg Biochem"},{"key":"10.1016\/j.drudis.2025.104522_b0060","doi-asserted-by":"crossref","first-page":"2589","DOI":"10.1007\/s12598-024-03058-0","article-title":"Design of a theranostic Gd (III)\u2013Cu (I) complex to inhibit growth and metastasis of triple-negative breast cancer","volume":"44","author":"Man","year":"2025","journal-title":"Rare Met"},{"key":"10.1016\/j.drudis.2025.104522_b0065","doi-asserted-by":"crossref","first-page":"15606","DOI":"10.1021\/acs.jmedchem.4c01273","article-title":"Rational design of a hetero-multinuclear gadolinium(III)-copper(II) complex: integrating magnetic resonance imaging, photoacoustic imaging, mild photothermal therapy, chemotherapy and immunotherapy of cancer","volume":"67","author":"Man","year":"2024","journal-title":"J Med Chem"},{"key":"10.1016\/j.drudis.2025.104522_b0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2023.101018","article-title":"Cuproptosis: a novel therapeutic target for overcoming cancer drug resistance","volume":"72","author":"Wang","year":"2024","journal-title":"Drug Resist Updat"},{"key":"10.1016\/j.drudis.2025.104522_b0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2023.189013","article-title":"Cuproptosis and cuproptosis-related genes: emerging potential therapeutic targets in breast cancer","volume":"1878","author":"Liu","year":"2023","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"10.1016\/j.drudis.2025.104522_b0080","article-title":"Current state of research on copper complexes in the treatment of breast cancer","volume":"19","author":"Hu","year":"2024","journal-title":"Open Life Sci"},{"key":"10.1016\/j.drudis.2025.104522_b0085","series-title":"Metallo-Drugs: Development and Action of Anticancer Agents","first-page":"1","year":"2018"},{"key":"10.1016\/j.drudis.2025.104522_b0090","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1021\/cr400135x","article-title":"Advances in copper complexes as anticancer agents","volume":"114","author":"Santini","year":"2014","journal-title":"Chem Rev"},{"key":"10.1016\/j.drudis.2025.104522_b0095","doi-asserted-by":"crossref","first-page":"112","DOI":"10.2174\/0929867323666160824162546","article-title":"Vanadium, ruthenium and copper compounds: a new class of nonplatinum metallodrugs with anticancer activity","volume":"24","author":"Leon","year":"2016","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.drudis.2025.104522_b0100","doi-asserted-by":"crossref","DOI":"10.1002\/cmdc.202400060","article-title":"Copper and copper complexes in tumor therapy","volume":"19","author":"Wang","year":"2024","journal-title":"ChemMedChem"},{"key":"10.1016\/j.drudis.2025.104522_b0105","doi-asserted-by":"crossref","first-page":"134","DOI":"10.3390\/molecules23010134","article-title":"Synthesis and pharmacological activities of pyrazole derivatives: a review","volume":"23","author":"Karrouchi","year":"2018","journal-title":"Molecules"},{"key":"10.1016\/j.drudis.2025.104522_b0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.jinorgbio.2022.112013","article-title":"Synthesis, characterization, antioxidant potential, and cytotoxicity screening of new Cu(II) complexes with 4-(arylchalcogenyl)-1H-pyrazoles ligands","volume":"237","author":"Pinheiro","year":"2022","journal-title":"J Inorg Biochem"},{"key":"10.1016\/j.drudis.2025.104522_b0115","doi-asserted-by":"crossref","first-page":"2539","DOI":"10.1039\/D2OB01224C","article-title":"Water-soluble copper pyrithione complexes with cytotoxic and antibacterial activity","volume":"21","author":"Mishra","year":"2023","journal-title":"Org Biomol Chem"},{"key":"10.1016\/j.drudis.2025.104522_b0120","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1039\/D4MD00610K","article-title":"Anticancer potential of copper(I) complexes based on isopropyl ester derivatives of bis(pyrazol-1-yl)acetate ligands","volume":"16","author":"Pellei","year":"2025","journal-title":"RSC Med Chem"},{"key":"10.1016\/j.drudis.2025.104522_b0125","doi-asserted-by":"crossref","first-page":"3238","DOI":"10.1039\/D1QI00233C","article-title":"Water-mediated reduction of [Cu(dmp)2(CH3CN)]2+: implications of the structure of a classical complex on its activity as an anticancer drug","volume":"8","author":"Levin","year":"2021","journal-title":"Inorg Chem Front"},{"key":"10.1016\/j.drudis.2025.104522_b0130","doi-asserted-by":"crossref","first-page":"896","DOI":"10.3390\/molecules28020896","article-title":"New copper(II)-L-dipeptide-bathophenanthroline complexes as potential anticancer agents\u2014synthesis, characterization and cytotoxicity studies\u2014and comparative DNA-binding study of related phen complexes","volume":"28","author":"Fern\u00e1ndez","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.drudis.2025.104522_b0135","doi-asserted-by":"crossref","first-page":"747","DOI":"10.3390\/pharmaceutics16060747","article-title":"L-citrullinato-bipyridine and L-citrullinato-phenanthroline mixed copper complexes: synthesis, characterization and potential anticancer activity","volume":"16","author":"Ram\u00edrez-Contreras","year":"2024","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.drudis.2025.104522_b0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.jinorgbio.2023.112443","article-title":"8-Hydroxyquinoline-N-oxide copper(II)- and zinc(II)-phenanthroline and bipyridine coordination compounds: design, synthesis, structures, and antitumor evaluation","volume":"251","author":"Du","year":"2024","journal-title":"J Inorg Biochem"},{"key":"10.1016\/j.drudis.2025.104522_b0145","doi-asserted-by":"crossref","first-page":"3039","DOI":"10.1039\/D3DT02964F","article-title":"New copper(II) and oxidovanadium(IV) complexes with a vitamin B6 Schiff base: mechanism of action and synergy studies on 2D and 3D human osteosarcoma cell models","volume":"53","author":"Balsa","year":"2024","journal-title":"Dalton Trans"},{"key":"10.1016\/j.drudis.2025.104522_b0150","doi-asserted-by":"crossref","first-page":"7626","DOI":"10.1039\/D3DT00738C","article-title":"A copper complex that combats triple negative breast cancer by restraining angiogenesis","volume":"52","author":"Zheng","year":"2023","journal-title":"Dalton Trans"},{"key":"10.1016\/j.drudis.2025.104522_b0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.poly.2021.115621","article-title":"Tridentate acylhydrazone copper(II) complexes with heterocyclic bases as coligands. Synthesis, spectroscopic studies, crystal structure and cytotoxicity assays","volume":"213","author":"Burgos-L\u00f3pez","year":"2022","journal-title":"Polyhedron"},{"key":"10.1016\/j.drudis.2025.104522_b0160","doi-asserted-by":"crossref","first-page":"4925","DOI":"10.1021\/acs.inorgchem.3c04085","article-title":"Promising dual anticancer and antimetastatic action by a Cu(II) complex derived from acylhydrazone on human osteosarcoma models","volume":"63","author":"Santa Maria de la Parra","year":"2024","journal-title":"Inorg Chem"},{"key":"10.1016\/j.drudis.2025.104522_b0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2023.110685","article-title":"Cu(II)-acylhydrazone complex, a potent and selective antitumor agent against human osteosarcoma: mechanism of action studies over in vitro and in vivo models","volume":"384","author":"Balsa","year":"2023","journal-title":"Chem Biol Interact"},{"key":"10.1016\/j.drudis.2025.104522_b0170","doi-asserted-by":"crossref","DOI":"10.1002\/cbic.202400373","article-title":"Deciphering the effect of a Cu(II)\u2010hydrazone complex on intracellular cell signalling pathways in a human osteosarcoma 2D and 3D models","volume":"25","author":"Balsa","year":"2024","journal-title":"Chembiochem"},{"key":"10.1016\/j.drudis.2025.104522_b0175","doi-asserted-by":"crossref","first-page":"7531","DOI":"10.3390\/ijms24087531","article-title":"Finding new molecular targets of two copper(II)-hydrazone complexes on triple-negative breast cancer cells using mass-spectrometry-based quantitative proteomics","volume":"24","author":"Balsa","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.drudis.2025.104522_b0180","doi-asserted-by":"crossref","first-page":"3872","DOI":"10.1039\/D4DT03445G","article-title":"Antiproliferative activity of a series of copper(II) complexes derived from a furan-containing N-acylhydrazone: monomers, dimers, charge status, and cell mechanistic studies on triple negative breast cancer cells","volume":"54","author":"Espindola-Moreno","year":"2025","journal-title":"Dalton Trans"},{"key":"10.1016\/j.drudis.2025.104522_b0185","doi-asserted-by":"crossref","DOI":"10.3389\/fchem.2023.1106349","article-title":"Promising anticancer agents based on 8-hydroxyquinoline hydrazone copper(II) complexes","volume":"11","author":"Ribeiro","year":"2023","journal-title":"Front Chem"},{"key":"10.1016\/j.drudis.2025.104522_b0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.jinorgbio.2024.112550","article-title":"Development of Cu(II) 4-hydroxybenzoylhydrazone complexes that induce mitochondrial DNA damage and mitochondria-mediated apoptosis in liver cancer","volume":"256","author":"Jiang","year":"2024","journal-title":"J Inorg Biochem"},{"key":"10.1016\/j.drudis.2025.104522_b0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.jinorgbio.2022.112108","article-title":"Anticancer and antimicrobial activity of new copper (II) complexes","volume":"240","author":"Climova","year":"2023","journal-title":"J Inorg Biochem"},{"key":"10.1016\/j.drudis.2025.104522_b0200","doi-asserted-by":"crossref","first-page":"12318","DOI":"10.1039\/D3DT01750H","article-title":"Hydrazylpyridine salicylaldehyde-copper(ii)-1,10-phenanthroline complexes as potential anticancer agents: synthesis, characterization and anticancer evaluation","volume":"52","author":"Chen","year":"2023","journal-title":"Dalton Trans"},{"key":"10.1016\/j.drudis.2025.104522_b0205","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.3390\/molecules30092077","article-title":"Thiosemicarbazone-based compounds: cancer cell inhibitors with antioxidant properties","volume":"30","author":"Garbuz","year":"2025","journal-title":"Molecules"},{"key":"10.1016\/j.drudis.2025.104522_b0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.carres.2023.108796","article-title":"Synthesis, characterization, and anticancer activity of chitosan functionalized isatin based thiosemicarbazones, and their copper(II) complexes","volume":"526","author":"Adhikari","year":"2023","journal-title":"Carbohydr Res"},{"key":"10.1016\/j.drudis.2025.104522_b0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.jinorgbio.2023.112403","article-title":"Novel mono-, bi-, tri- and tetra-nuclear copper complexes that inhibit tumor growth through apoptosis and anti-angiogenesis","volume":"250","author":"Wang","year":"2024","journal-title":"J Inorg Biochem"},{"key":"10.1016\/j.drudis.2025.104522_b0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116697","article-title":"Anticancer activity of new water-soluble sulfonated thiosemicarbazone copper(II) complexes targeting disulfide isomerase","volume":"276","author":"Miglioli","year":"2024","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.drudis.2025.104522_b0225","doi-asserted-by":"crossref","DOI":"10.1093\/mtomcs\/mfad037","article-title":"D\u2019Yakonov VA. Mono- and binuclear complexes of copper(II) with dimethylaminomethyl derivatives of 2-naphthol and 6-quinolinol: synthesis and in vitro study of antitumor properties","volume":"15","author":"Akhmetova","year":"2023","journal-title":"Metallomics"},{"key":"10.1016\/j.drudis.2025.104522_b0230","doi-asserted-by":"crossref","first-page":"e7510","DOI":"10.1002\/aoc.7510","article-title":"High anticancer activity in short response time exhibited by a new azobenzene derivative and its copper complex","volume":"38","author":"Dev","year":"2024","journal-title":"Appl Organomet Chem"},{"key":"10.1016\/j.drudis.2025.104522_b0235","doi-asserted-by":"crossref","first-page":"11697","DOI":"10.1039\/D4DT00984C","article-title":"Mononuclear copper(II) complexes with polypyridyl ligands: synthesis, characterization, DNA interactions\/cleavages and in vitro cytotoxicity towards human cancer cells","volume":"53","author":"Muley","year":"2024","journal-title":"Dalton Trans"},{"key":"10.1016\/j.drudis.2025.104522_b0240","doi-asserted-by":"crossref","first-page":"4876","DOI":"10.3390\/molecules28124876","article-title":"Anticancer activity and mode of action of Cu(II), Zn(II), and Mn(II) complexes with 5-chloro-2-N-(2-quinolylmethylene)aminophenol","volume":"28","author":"Gai","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.drudis.2025.104522_b0245","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.3390\/biomedicines12081763","article-title":"Heteronuclear complexes with promising anticancer activity against colon cancer","volume":"12","author":"Atri\u00e1n-Blasco","year":"2024","journal-title":"Biomedicines"},{"key":"10.1016\/j.drudis.2025.104522_b0250","doi-asserted-by":"crossref","first-page":"8803","DOI":"10.3390\/ijms25168803","article-title":"Antitumoral and antimetastatic activity by mixed chelate copper(II) compounds (Casiope\u00ednas\u00ae) on triple-negative breast cancer, in vitro and in vivo models","volume":"25","author":"Gonz\u00e1lez-Ballesteros","year":"2024","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.drudis.2025.104522_b0255","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2024.107122","article-title":"Assessment of mononuclear\/dinuclear copper acylhydrazone complexes for lung cancer treatment","volume":"144","author":"Wu","year":"2024","journal-title":"Bioorg Chem"},{"key":"10.1016\/j.drudis.2025.104522_b0260","doi-asserted-by":"crossref","DOI":"10.1016\/j.jinorgbio.2024.112481","article-title":"Dinuclear copper(II) complexes with a bridging bis(chalcone) ligand reveal considerable in vitro cytotoxicity on human cancer cells and enhanced selectivity","volume":"252","author":"Tr\u00e1vn\u00ed\u010dek","year":"2024","journal-title":"J Inorg Biochem"},{"key":"10.1016\/j.drudis.2025.104522_b0265","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.jinorgbio.2015.05.007","article-title":"Reactivity of dinuclear copper(II) complexes towards melanoma cells: correlation with its stability, tyrosinase mimicking and nuclease activity","volume":"149","author":"Nunes","year":"2015","journal-title":"J Inorg Biochem"},{"key":"10.1016\/j.drudis.2025.104522_b0270","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.canlet.2023.216157","article-title":"Cope with copper: from copper linked mechanisms to copper-based clinical cancer therapies","volume":"561","author":"Wang","year":"2023","journal-title":"Cancer Lett"},{"key":"10.1016\/j.drudis.2025.104522_b0275","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s00432-024-05641-5","article-title":"Unveiling the promising anticancer effect of copper-based compounds: a comprehensive review","volume":"150","author":"Abdolmaleki","year":"2024","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1016\/j.drudis.2025.104522_b0280","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12943-023-01732-y","article-title":"Cuproptosis: mechanisms and links with cancers","volume":"22","author":"Xie","year":"2023","journal-title":"Mol Cancer"},{"key":"10.1016\/j.drudis.2025.104522_b0285","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1126\/science.abf0529","article-title":"Copper induces cell death by targeting lipoylated TCA cycle proteins","volume":"375","author":"Tsvetkov","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.drudis.2025.104522_b0290","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13045-024-01589-8","article-title":"Targeting cuproptosis for cancer therapy: mechanistic insights and clinical perspectives","volume":"17","author":"Zhang","year":"2024","journal-title":"J Hematol Oncol"},{"key":"10.1016\/j.drudis.2025.104522_b0295","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1038\/s41423-022-00866-1","article-title":"Cuproptosis: a new form of programmed cell death","volume":"19","author":"Wang","year":"2022","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.drudis.2025.104522_b0300","doi-asserted-by":"crossref","DOI":"10.1002\/aoc.70324","article-title":"Copper(II) complexes of pyrazino [2,3-F][1,10]phenanthroline induce cuprotosis and immunogenic cell death in triple-negative breast cancer","volume":"39","author":"Li","year":"2025","journal-title":"Appl Organomet Chem"}],"container-title":["Drug Discovery Today"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359644625002351?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359644625002351?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T12:08:07Z","timestamp":1780920487000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1359644625002351"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":60,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S1359644625002351"],"URL":"https:\/\/doi.org\/10.1016\/j.drudis.2025.104522","relation":{},"ISSN":["1359-6446"],"issn-type":[{"value":"1359-6446","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Advances in copper complexes in cancer treatment","name":"articletitle","label":"Article Title"},{"value":"Drug Discovery Today","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drudis.2025.104522","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"104522"}}